Ocular Therapeutix Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Ocular Therapeutix

Access the complete profile.

Ocular Therapeutix Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 339115 Ophthalmic Goods Manufacturing
Address	24 Crosby Dr Bedford, MA 01730

Note: Revenues for privately held companies are statistical evaluations.


Ocular Therapeutix's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Ocular Therapeutix's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Ocular Therapeutix is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Ocular Therapeutix Annual Revenue and Growth Rate

Ocular Therapeutix	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Ocular Therapeutix's revenues are gauged from an analysis of company filings.

Ocular Therapeutix's Income Statement (based on Industry Averages)

Ocular Therapeutix P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Ocular Therapeutix is developing and marketing. Ocular Therapeutix doesn't have any recent trademark applications, indicating Ocular Therapeutix is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
AXTOKI Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of vision diseases, disorders and conditions; Pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Pharmaceutical preparations for the treatment of vision diseases, disorders and conditions	03/27/2023
EXTENLY Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of vision diseases, disorders and conditions; Pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Pharmaceutical preparations for the treatment of vision diseases, disorders and conditions	03/27/2023
AXPAXTLI Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of vision diseases, disorders and conditions; Pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Pharmaceutical preparations for the treatment of vision diseases, disorders and conditions	03/27/2023

See all trademarks and details in the Full Report.

Market Share of Ocular Therapeutix's Largest Competitors

A competitive analysis shows these companies are in the same general field as Ocular Therapeutix, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Ocular Therapeutix. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
IROBOT	Bedford, MA	100
LFB USA	Framingham, MA	16
OCULAR THERAPEUTIX	Bedford, MA	15
HOMOLOGY MEDICINE	Bedford, MA	11
AVANIA US GROUP	Marlborough, MA	10
Q-PEAK	Bedford, MA	10

Future Competition: Ocular Therapeutix's Fastest Growing Competitors

These companies are in the same general field as Ocular Therapeutix and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)